Integrated Filing — IndAS


General information about company

Scrip Code 500184
NSE Symbol HSCL
MSEI Symbol NOTLISTED
ISIN INE019C01026
Name of company Himadri Speciality Chemical Limited
Type of company Main Board
Class of security Equity
Date of start of financial year 01-Apr-2024
Date of end of financial year 31-Mar-2025
Date of board meeting when results were approved 21-Apr-2025
Date on which prior intimation of the meeting for considering financial results was informed to the exchange 14-Apr-2025
Description of presentation currency INR (in Actuals)
Reporting Type Quarterly
Reporting Quarter Fourth quarter
Nature of report standalone or consolidated Standalone
Whether results are audited or unaudited for the quarter ended Audited
Whether results are audited or unaudited for the Year to date for current period ended/year ended Audited
Segment Reporting Multi segment
Description of single segment
Start date and time of board meeting 21-Apr-2025   13:00:00
End date and time of board meeting 21-Apr-2025   16:45:00
Whether cash flow statement is applicable on company Yes
Type of cash flow statement Cash Flow Indirect
Declaration of unmodified opinion or statement on impact of audit qualification Declaration of unmodified opinion
Whether the company has any related party? Yes
Whether the company has entered into any Related Party transaction during the selected half year for which it wants to submit disclosure? Yes
(I) We declare that the acceptance of fixed deposits by the bans/Non-Banking Finance Company are at the terms uniformly applicable/offered to all shareholders/public NA
(II) We declare that the scheduled commercial bank, as per RBI circular RBI/DBR/2015-16/19 dated March 03, 2016, has allowed additional interest of one per cent per annum, over and above the rate of interest mentioned in the schedule of interest rates on savings or a term deposits of banks staff and their exclusive associations as well as on deposits of Chairman, Chairman & Managing Director, Executive Director or such other Executives appointed for a fixed tenure. NA
Whether the company is a high value debt listed entity according to regulation 15 (1A)? No
(a) If answer to above question is Yes, whether complying with proviso to regulation 23 (9), i.e., submitting RPT disclosures on the day of results publication?
(b) If answer to above question is No, please explain the reason for not complying.
Whether the updated Related Party Transactions (RPT) Policy (in compliance with Reg. 23 of SEBI LODR) has been uploaded on the website of the Company? Yes
Latest Date on which RPT policy is updated 2025-01-13
Indicate Company website link for updated RPT policy of the Company www.himadri.com
Whether statement on deviation or variation for proceeds of public issue, rights issue, preferential issue, qualified institutions placement etc. is applicable to the company for the current quarter? Yes
No. of times funds raised during the quarter 1
Whether the disclosure for the Default on Loans and Debt Securities is applicable to the entity? No
There is no default in the payment of outstanding Loans / revolving facilities, Unlisted debt securities.



Financial Results Ind-AS

Particulars 3 months/ 6 months ended (dd-mm-yyyy) Year to date figures for current period ended (dd-mm-yyyy)
A Date of start of reporting period 01-Jan-2025 01-Apr-2024
B Date of end of reporting period 31-Mar-2025 31-Mar-2025
C Whether results are audited or unaudited Audited Audited
D Nature of report standalone or consolidated Standalone Standalone
Part I Blue color marked fields are non-mandatory. For Consolidated Results, if the company has no figures for 3 months / 6 months ended, in such case zero shall be inserted in the said column.
1 Income
Revenue from operations 11290100000 45958000000
Other income 133700000 509000000
Total income 11423800000 46467000000
2 Expenses
(a) Cost of materials consumed 7124800000 31569900000
(b) Purchases of stock-in-trade 0 0
(c) Changes in inventories of finished goods, work-in-progress and stock-in-trade 320700000 -50100000
(d) Employee benefit expense 303000000 1243700000
(e) Finance costs 87100000 445700000
(f) Depreciation, depletion and amortisation expense 122600000 496200000
(f) Other Expenses
1 Other Expenses 1196800000 4684300000
Total other expenses 1196800000 4684300000
Total expenses 9155000000 38389700000
3 Total profit before exceptional items and tax 2268800000 8077300000
4 Exceptional items 0 0
5 Total profit before tax 2268800000 8077300000
6 Tax expense
7 Current tax 404100000 1418700000
8 Deferred tax 282400000 1078000000
9 Total tax expenses 686500000 2496700000
10 Net movement in regulatory deferral account balances related to profit or loss and the related deferred tax movement 0 0
11 Net Profit Loss for the period from continuing operations 1582300000 5580600000
12 Profit (loss) from discontinued operations before tax 0 0
13 Tax expense of discontinued operations 0 0
14 Net profit (loss) from discontinued operation after tax 0 0
15 Share of profit (loss) of associates and joint ventures accounted for using equity method 0 0
16 Total profit (loss) for period 1582300000 5580600000
17 Other comprehensive income net of taxes -26900000 153100000
18 Total Comprehensive Income for the period 1555400000 5733700000
19 Total profit or loss, attributable to
Profit or loss, attributable to owners of parent
Total profit or loss, attributable to non-controlling interests
20 Total Comprehensive income for the period attributable to
Comprehensive income for the period attributable to owners of parent
Total comprehensive income for the period attributable to owners of parent non-controlling interests
21 Details of equity share capital
Paid-up equity share capital 493800000 493800000
Face value of equity share capital 1 1
27 Details of debt securities
22 Reserves excluding revaluation reserve 35981500000
23 Earnings per share
i Earnings per equity share for continuing operations
Basic earnings (loss) per share from continuing operations 3.21 11.31
Diluted earnings (loss) per share from continuing operations 3.18 11.22
ii Earnings per equity share for discontinued operations
Basic earnings (loss) per share from discontinued operations 0 0
Diluted earnings (loss) per share from discontinued operations 0 0
ii Earnings per equity share
Basic earnings (loss) per share from continuing and discontinued operations 3.21 11.31
Diluted earnings (loss) per share from continuing and discontinued operations 3.18 11.22
24 Debt equity ratio
25 Debt service coverage ratio
26 Interest service coverage ratio
27 Disclosure of notes on financial results We have provided all figures and amount in integrated financial xbrl except notes on the financial results. The Notes on the financial results contains special characters and due to some technical issue in XBRL tool regarding special character error we are uploading the Integrated financial with NSE without notes to the financial results. Please note that if all special characters are removed the meaning of the notes on the financial results will change. nPlease refer the notes contains in PDF file of Financial Result Standalone & Consolidated for the financial year ended 31.03.2025 uploaded with NSE with outcome of Board meeting. n



Remarks

Debt equity ratio
Debt service coverage ratio
Interest service coverage ratio


Statement of Asset and Liabilities

Particulars Year ended (dd-mm-yyyy)
Date of start of reporting period 01-Apr-2024
Date of end of reporting period 31-Mar-2025
Whether results are audited or unaudited Audited
Nature of report standalone or consolidated Standalone
Assets
1 Non-current assets
Property, plant and equipment 14482300000
Capital work-in-progress 1764500000
Investment property 0
Goodwill 0
Other intangible assets 169900000
Intangible assets under development
Biological assets other than bearer plants
Investments accounted for using equity method
Non-current financial assets
Non-current investments 6277700000
Trade receivables, non-current 101800000
Loans, non-current 109000000
Other non-current financial assets 609700000
Total non-current financial assets 7098200000
Deferred tax assets (net) 88100000
Other non-current assets 407700000
Total non-current assets 24010700000
2 Current assets
Inventories 5859200000
Current financial asset
Current investments 0
Trade receivables, current 6277000000
Cash and cash equivalents 1530300000
Bank balance other than cash and cash equivalents 5167100000
Loans, current 18300000
Other current financial assets 232800000
Total current financial assets 13225500000
Current tax assets (net) 0
Other current assets 2126200000
Total current assets 21210900000
3 Non-current assets classified as held for sale 0
4 Regulatory deferral account debit balances and related deferred tax Assets 0
Total assets 45221600000
Equity and liabilities
1 Equity
Equity attributable to owners of parent
Equity share capital 493800000
Other equity 35981500000
Total equity attributable to owners of parent 36475300000
Non controlling interest
Total equity 36475300000
2 Liabilities
Non-current liabilities
Non-current financial liabilities
Borrowings, non-current 22000000
Trade payables, non-current
(A) Total outstanding dues of micro enterprises and small enterprises 0
(B) Total outstanding dues of creditors other than micro enterprises and small enterprises 0
Total Trade payable 0
Other non-current financial liabilities 16600000
Total non-current financial liabilities 38600000
Provisions, non-current 110900000
Deferred tax liabilities (net) 2632600000
Deferred government grants, Non-current 0
Other non-current liabilities 0
Total non-current liabilities 2782100000
Current liabilities
Current financial liabilities
Borrowings, current 3056000000
Trade payables, current
(A) Total outstanding dues of micro enterprises and small enterprises 49700000
(B) Total outstanding dues of creditors other than micro enterprises and small enterprises 2298100000
Total Trade payable 2347800000
Other current financial liabilities 388800000
Total current financial liabilities 5792600000
Other current liabilities 71500000
Provisions, current 4500000
Current tax liabilities (Net) 95600000
Deferred government grants, Current 0
Total current liabilities 5964200000
3 Liabilities directly associated with assets in disposal group classified as held for sale 0
4 Regulatory deferral account credit balances and related deferred tax liability 0
Total liabilities 8746300000
Total equity and liabilites 45221600000
Disclosure of notes on assets and liabilities



Format for Reporting Segmenet wise Revenue, Results and Capital Employed along with the company results

Particulars 3 months/ 6 month ended (dd-mm-yyyy) Year to date figures for current period ended (dd-mm-yyyy)
Date of start of reporting period 01-Jan-2025 01-Apr-2024
Date of end of reporting period 31-Mar-2025 31-Mar-2025
Whether accounts are audited or unaudited Audited Audited
Nature of report standalone or consolidated Standalone Standalone
1 Segment Revenue (Income)
(net sale/income from each segment should be disclosed)
1 Carbon materials and chemicals 11229400000 45721100000
2 Power 249800000 1047300000
Total Segment Revenue 11479200000 46768400000
Less: Inter segment revenue 189100000 189100000
Revenue from operations 11290100000 45958000000
2 Segment Result
Profit (+) / Loss (-) before tax and interest from each segment
1 Carbon materials and chemicals 1980900000 7010000000
2 Power 218600000 929300000
Total Profit before tax 2199500000 7939300000
i. Finance cost 87100000 87100000
ii. Other Unallocable Expenditure net off Unallocable income -156400000 -156400000
Profit before tax 2268800000 8077300000
3 (Segment Asset - Segment Liabilities)
Segment Asset
1 Carbon materials and chemicals 30669000000 30669000000
2 Power 1035400000 1035400000
Total Segment Asset 31704400000 31704400000
Un-allocable Assets 13517200000 13517200000
Net Segment Asset 45221600000 45221600000
4 Segment Liabilities
Segment Liabilities
1 Carbon materials and chemicals 2841900000 2841900000
2 Power 6100000 6100000
Total Segment Liabilities 2848000000 2848000000
Un-allocable Liabilities 5898300000 5898300000
Net Segment Liabilities 8746300000 8746300000
Disclosure of notes on segments



Other Comprehensive Income

Particulars 3 months/ 6 months ended (dd-mm-yyyy) Year to date figures for current period ended (dd-mm-yyyy)
A Date of start of reporting period 01-Jan-2025 01-Apr-2024
B Date of end of reporting period 31-Mar-2025 31-Mar-2025
C Whether results are audited or unaudited Audited Audited
D Nature of report standalone or consolidated Standalone Standalone
Other comprehensive income [Abstract]
1 Amount of items that will not be reclassified to profit and loss
1 Remeasurements of the net defined benefit plan -8800000 -10300000
2 Net gain/ (loss) on investment in equity instruments accounted at fair value -23700000 26700000
Total Amount of items that will not be reclassified to profit and loss -32500000 16400000
2 Income tax relating to items that will not be reclassified to profit or loss -5600000 -136700000
3 Amount of items that will be reclassified to profit and loss
Total Amount of items that will be reclassified to profit and loss
4 Income tax relating to items that will be reclassified to profit or loss 0 0
5 Total Other comprehensive income -26900000 153100000



Cash flow statement, indirect

Particulars Year ended (dd-mm-yyyy)
A Date of start of reporting period 2024-04-01
B Date of end of reporting period 2025-03-31
C Whether results are audited or unaudited Audited
D Nature of report standalone or consolidated Standalone
Part I Blue color marked fields are non-mandatory.
Statement of cash flows
Cash flows from used in operating activities
Profit before tax 8077300000
Adjustments for reconcile profit (loss)
Adjustments for finance costs 445700000
Adjustments for decrease (increase) in inventories 1201600000
Adjustments for decrease (increase) in trade receivables, current 307400000
Adjustments for decrease (increase) in trade receivables, non-current 0
Adjustments for decrease (increase) in other current assets 0
Adjustments for decrease (increase) in other non-current assets 0
Adjustments for other financial assets, non-current 0
Adjustments for other financial assets, current -961500000
Adjustments for other bank balances 0
Adjustments for increase (decrease) in trade payables, current -3101200000
Adjustments for increase (decrease) in trade payables, non-current 0
Adjustments for increase (decrease) in other current liabilities -88100000
Adjustments for increase (decrease) in other non-current liabilities 0
Adjustments for depreciation and amortisation expense 496200000
Adjustments for impairment loss reversal of impairment loss recognised in profit or loss 0
Adjustments for provisions, current 0
Adjustments for provisions, non-current 0
Adjustments for other financial liabilities, current 56400000
Adjustments for other financial liabilities, non-current 0
Adjustments for unrealised foreign exchange losses gains 13400000
Adjustments for dividend income 0
Adjustments for interest income 444000000
Adjustments for share-based payments 0
Adjustments for fair value losses (gains) -34300000
Adjustments for undistributed profits of associates 0
Other adjustments for which cash effects are investing or financing cash flow 0
Other adjustments to reconcile profit (loss) 0
Other adjustments for non-cash items 100000
Share of profit and loss from partnership firm or association of persons or limited liability partnerships 0
Total adjustments for reconcile profit (loss) -2108300000
Net cash flows from (used in) operations 5969000000
Dividends received 0
Interest paid 0
Interest received 0
Income taxes paid (refund) 1418700000
Other inflows (outflows) of cash 0
Net cash flows from (used in) operating activities 4550300000
Cash flows from used in investing activities
Cash flows from losing control of subsidiaries or other businesses 0
Cash flows used in obtaining control of subsidiaries or other businesses 245600000
Other cash receipts from sales of equity or debt instruments of other entities 0
Other cash payments to acquire equity or debt instruments of other entities 951800000
Other cash receipts from sales of interests in joint ventures 0
Other cash payments to acquire interests in joint ventures 0
Cash receipts from share of profits of partnership firm or association of persons or limited liability partnerships 0
Cash payment for investment in partnership firm or association of persons or limited liability partnerships 0
Proceeds from sales of property, plant and equipment 900000
Purchase of property, plant and equipment 1616500000
Proceeds from sales of investment property 0
Purchase of investment property 0
Proceeds from sales of intangible assets 0
Purchase of intangible assets 0
Proceeds from sales of intangible assets under development 0
Purchase of intangible assets under development 0
Proceeds from sales of goodwill 0
Purchase of goodwill 0
Proceeds from biological assets other than bearer plants 0
Purchase of biological assets other than bearer plants 0
Proceeds from government grants 0
Proceeds from sales of other long-term assets 0
Purchase of other long-term assets 0
Cash advances and loans made to other parties 98500000
Cash receipts from repayment of advances and loans made to other parties 0
Cash payments for future contracts, forward contracts, option contracts and swap contracts 0
Cash receipts from future contracts, forward contracts, option contracts and swap contracts 0
Dividends received 0
Interest received 496300000
Income taxes paid (refund) 0
Other inflows (outflows) of cash -200000
Net cash flows from (used in) investing activities -2415400000
Cash flows from used in financing activities
Proceeds from changes in ownership interests in subsidiaries 0
Payments from changes in ownership interests in subsidiaries 0
Proceeds from issuing shares 32000000
Proceeds from issuing other equity instruments 892500000
Payments to acquire or redeem entity's shares 0
Payments of other equity instruments 0
Proceeds from exercise of stock options 0
Proceeds from issuing debentures notes bonds etc 0
Proceeds from borrowings 0
Repayments of borrowings 2946600000
Payments of lease liabilities 11000000
Dividends paid 246800000
Interest paid 418300000
Income taxes paid (refund) 0
Other inflows (outflows) of cash -300000
Net cash flows from (used in) financing activities -2698500000
Net increase (decrease) in cash and cash equivalents before effect of exchange rate changes -563600000
Effect of exchange rate changes on cash and cash equivalents
Effect of exchange rate changes on cash and cash equivalents -100000
Net increase (decrease) in cash and cash equivalents -563700000
Cash and cash equivalents cash flow statement at beginning of period 2094000000
Cash and cash equivalents cash flow statement at end of period 1530300000







Details of Impact of Audit Qualification

Whether results are audited or unaudited Audited
Declaration of unmodified opinion or statement on impact of audit qualification Declaration of unmodified opinion
Auditor's opinion
Declaration pursuant to Regulation 33 (3) (d) of SEBI (LODR) Regulation, 2015: The company declares that its Statutory Auditor/s have issued an Audit Report with unmodified opinion for the period on Standalone results Yes
Sr No. Audit firm's name Whether the firm holds a valid peer review certificate issued by Peer Review Board of ICAI Certificate valid upto
1 Singhi and Co Yes 31-Aug-2025


Financial details

Sr. Particulars Audited Figures (as reported before adjusting for qualifications) Adjusted Figures (audited figures after adjusting for qualifications)
1 Turnover / Total income
2 Total Expenditure
3 Net Profit/(Loss)
4 Earnings Per Share
5 Total Assets
6 Total Liabilities
7 Net Worth




Signatories detail

Name of CEO / Managing director
Name of CFO
Name of audit committee chairman
Name of statutory auditor
Name of other signatory, if any, with designation
Place
Date



Statement on Deviation or Variation for proceeds of Public Issue, Rights Issue, Preferential Issue, Qualified Institutions Placement Etc. (1)

Mode of Fund Raising Preferential Issues
Description of mode of fund raising (Applicable in case of others is selected)
Date of Raising Funds 05-Mar-2025
Amount Raised 23900000
Report filed for Quarter ended 31-Mar-2025
Monitoring Agency Applicable
Monitoring Agency Name, if applicable ICRA Limited
Is there a Deviation / Variation in use of funds raised No
If yes, whether the same is pursuant to change in terms of a contract or objects, which was approved by the shareholders
If Yes, Date of shareholder Approval
Explanation for the Deviation / Variation
Comments of the Audit Committee after review
Comments of the auditors, if any
Sr. Original Object Modified Object, if any Original Allocation Modified allocation, if any Funds Utilised Amount of Deviation/Variation for the quarter according to applicable object Remarks if any
1 To Fund Capital expenditure for newngreen fields project or capital expenditure in its existing units and projects i.e. brown field expansion directly by the Company and/or through its subsidiaries or jointnventures or associates for the growth of existingnbusinesses or to enter into new business in line withnthe strategy of the Company. Not Applicable 2568200000 0 63800000 0 Out of this Rs 3.99 Crore utilised upto the quarter ended 31 December 2024 and Rs 2.39 Crore utilised during the quarter ended 31 March 2025
2 To Fund General corporate purposes,nwhich includes, inter alia, meeting ongoing general corporate exigencies and contingencies, expenses of the Company as applicable in such a manner andnproportion as may be decided by the Board from time to time, and/or any other general purposes as may be permissible under applicable laws Not Applicable 850000000 0 828600000 0 Rs 82.86 Crore has been utilised by the Company by the quarter ended 30 June 2024


Signatory Details

Name of signatory Monika Saraswat
Designation of person Company Secretary and Compliance Officer
Place Kolkata
Date 21-Apr-2025




Format for Disclosure of Related Party Transactions (applicable only for half-yearly filings i.e., 2nd and 4th quarter)

Sr No. Additional disclosure of related party transactions - applicable only in case the related party transaction relates to loans, inter-corporate deposits, advances or investments made or given by the listed entity/subsidiary. These details need to be disclosed only once, during the reporting period when such transaction was undertaken.
Details of the party (listed entity /subsidiary) entering into the transaction Details of the counterparty Type of related party transaction Details of other related party transaction Value of the related party transaction as approved by the audit committee Remarks on approval by audit committee Value of transaction during the reporting period In case monies are due to either party as a result of the transaction In case any financial indebtedness is incurred to make or give loans, inter-corporate deposits, advances or investments Details of the loans, inter-corporate deposits, advances or investments Notes
Name PAN Name PAN Relationship of the counterparty with the listed entity or its subsidiary Opening balance Closing balance Nature of indebtedness (loan/ issuance of debt/ any other etc.) Details of other indebtedness Cost Tenure Nature (loan/ advance/ intercorporate deposit/ investment ) Interest Rate (%) Tenure Secured/ unsecured Purpose for which the funds will be utilised by the ultimate recipient of funds (endusage)
1 Himadri Speciality Chemical Ltd AAT Global Limited Subsidiaries Purchase of goods or services 20000000000 Approved by Audit Committee 3829400000 217300000 155000000
2 Himadri Speciality Chemical Ltd AAT Global Limited Subsidiaries Any other transaction Payment of Supplies 20000000000 Approved by Audit Committee 3776000000 0 0
3 Himadri Speciality Chemical Ltd Himadri Clean Energy Limited Subsidiaries Interest received 40000000 Approved by Audit Committee 1100000 0 0
4 Himadri Speciality Chemical Ltd Himadri Green Technologies Innovation Limited Subsidiaries Loan 500000000 Approved by Audit Committee 22000000 35000000 57000000
5 Himadri Speciality Chemical Ltd Himadri Green Technologies Innovation Limited Subsidiaries Interest received 2100000 Approved by Audit Committee 2100000 0 0
6 Himadri Speciality Chemical Ltd HIMADRI FUTURE MATERIAL TECHNOLOGY LIMITED Subsidiaries Loan 500000000 Approved by Audit Committee 25000000 0 25000000
7 Himadri Speciality Chemical Ltd HIMADRI FUTURE MATERIAL TECHNOLOGY LIMITED Subsidiaries Interest received 500000 Approved by Audit Committee 500000 0 0
8 Himadri Speciality Chemical Ltd Mr. Shyam Sundar Choudhary Executive Director Remuneration 50000000 Approved by Audit Committee 15000000 0 0
9 Himadri Speciality Chemical Ltd Mr. Anurag Choudhary Chairman Cum Managing Director and Chief Executive Officer Remuneration 50000000 Approved by Audit Committee 23600000 0 0
10 Himadri Speciality Chemical Ltd Mr. Amit Choudhary Executive Director Remuneration 50000000 Approved by Audit Committee 20600000 0 0
11 Himadri Speciality Chemical Ltd Mr. Kamlesh Kumar Agarwal Chief Financial Officer KMP Interest received 800000 Approved by Audit Committee 300000 3100000 3400000
12 Himadri Speciality Chemical Ltd Himadri Foundation Enterprises controlled by the Key Managerial Personnel or relatives of KMP or both Any other transaction Donation Expenditure on corporate social responsibility 150000000 Approved by Audit Committee 29200000 0 0
13 Himadri Speciality Chemical Ltd Transaction Square LLP Firm in which director is a partner Any other transaction Consultancy Expenses 30000000 Approved by Audit Committee 7900000 0 3800000
14 Himadri Speciality Chemical Ltd Mr. Amritesh Choudhary Relative of Director Remuneration 28700000 Approved by Audit Committee 800000 0 0
15 Himadri Speciality Chemical Ltd Mr. Samridh Choudhary Relative of Director Remuneration 28700000 Approved by Audit Committee 800000 0 0
16 Himadri Speciality Chemical Ltd Next Generation Traders Pvt Ltd Enterprises controlled by the Key Managerial Personnel or relatives of KMP or both Any other transaction Rent paid 144000000 Approved by Audit Committee 72000000 0 0
17 Himadri Speciality Chemical Ltd Himadri Birla Tyre Manufacturer Pvt. Ltd Enterprises controlled by the Key Managerial Personnel or relatives of KMP or both Interest received 1500000 Approved by Audit Committee 100000 0 0
18 Himadri Speciality Chemical Ltd Aditya Energy Consultancy Firm in which director is a partner Any other transaction Consultancy Expenses 20000000 Approved by Audit Committee 6000000 0 900000
19 Himadri Speciality Chemical Ltd Tarun Kumar Pan Director in Subsidiary Any other transaction Consultancy Expenses 900000 Approved by Audit Committee 500000 0 0
20 AAT Global Limited Shandong Dawn Himadri Chemical Industry Limited Subsidiary Any other transaction Reimburshment of manpower suppoot NA 2700000 0 0 Textual Information(1)
21 AAT Global Limited Shandong Dawn Himadri Chemical Industry Limited Subsidiary Any other transaction Support Fee for procurement NA 4500000 0 0 Textual Information(2)
Total value of transaction during the reporting period 7840100000



Text Block

Textual Information(1) Transaction is held between two foreign subsidiary. PAN provided is dummy PAN
Textual Information(2) Transaction is held between two foreign subsidiary. PAN provided is dummy PAN


Format for Disclosing Outstanding Default on Loans and Debt Securities

Sr. No. Particulars Amount Remarks
1. Loans / revolving facilities like cash credit from banks / financial institutions
A Total amount outstanding as on date
B Of the total amount outstanding, amount of default as on date
2. Unlisted debt securities i.e. NCDs and NCRPS
A Total amount outstanding as on date
B Of the total amount outstanding, amount of default as on date
3. Total financial indebtedness of the listed entity including short-term and long-term debt